Reduction in albuminuria predicts future benefits on CV and renal outcomes in T2DM
This video was recorded in response to a recent publication in Diabetes Care by Frederik Persson and colleagues.
Frederik Persson, MD is senior researcher working at Steno Diabetes Center Copenhagen, Denmark.
This recording was developed under auspices of PACE-cme. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-cme.
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: